Bio-3D printing startup HUAQING ZHIMEI has secured tens of millions of yuan in Series A funding to a...

Bio-3D printing startup HUAQING ZHIMEI has secured tens of millions of yuan in Series A funding to accelerate the clinical translation of regenerative treatments. This investment signals a critical move in the AM industry toward the high-precision fabrication of functional skin and dental grafts. By integrating exosome-loaded hydrogels with bioprinting technology, the company is pushing the sector beyond structural scaffolds into bioactive tissue repair. This funding facilitates the industrialization of personalized healthcare, bridging the gap between laboratory research and scalable clinical applications. 🧬🚀 #3DPrinting #Bioprinting #Funding #RegenerativeMedicine #MedTech